{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:43:49Z","timestamp":1790786629424,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30 EY016665"],"award-info":[{"award-number":["P30 EY016665"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajoc.2021.101115","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T02:07:12Z","timestamp":1620007632000},"page":"101115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Uveitis reactivation following recombinant zoster vaccination"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-9234","authenticated-orcid":false,"given":"Paige J.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-557X","authenticated-orcid":false,"given":"Maxwell J.","family":"Wingelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-4756","authenticated-orcid":false,"given":"Karen R.","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Kopplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2021.101115_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15585\/mmwr.mm6804a4","article-title":"Postlicensure safety surveillance of recombinant zoster vaccine (Shingrix) - United States, october 2017-june 2018","volume":"68","author":"Hesse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajoc.2021.101115_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/21645515.2017.1317410","article-title":"A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ\/Su or GSK1437173A) for varicella zoster virus","volume":"13","author":"Bharucha","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ajoc.2021.101115_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajoc.2021.101115_bib4","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.vaccine.2019.03.043","article-title":"Safety profile of the adjuvanted recombinant zoster vaccine: pooled analysis of two large randomised phase 3 trials","volume":"37","author":"L\u00f3pez-Fauqued","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ajoc.2021.101115_bib5","article-title":"Uveitis sarcoidosis presumably initiated after administration of Shingrix vaccine","volume":"11","author":"Heydari-Kamjani","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ajoc.2021.101115_bib6","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.ajoc.2020.100962","article-title":"Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine","volume":"20","author":"Chen","year":"2020","journal-title":"American Journal of Ophthalmology Case Reports"},{"key":"10.1016\/j.ajoc.2021.101115_bib7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ophtha.2018.08.030","article-title":"Reactivation of Herpes Zoster Stromal Keratitis After HZ\/su Adjuvanted Herpes Zoster Subunit Vaccine","volume":"125","author":"Lehmann","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101115_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0000000000002537","article-title":"Presumed herpes zoster ophthalmicus reactivation following recombinant zoster vaccination","volume":"40","author":"Jabbour","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2021.101115_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00003226-199303000-00007","article-title":"Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus","volume":"12","author":"Wenkel","year":"1993","journal-title":"Cornea"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993621001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993621001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:00:34Z","timestamp":1762527634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993621001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":9,"alternative-id":["S2451993621001249"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2021.101115","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveitis reactivation following recombinant zoster vaccination","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2021.101115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101115"}}